When does ocular GVHD start?

Often in the chronic phase, months after transplant — any new eye symptoms after transplant deserve prompt evaluation.

Can ocular GVHD be cured?

It is controlled rather than cured: the goal is a comfortable, protected surface and preserved vision while your systemic disease is managed.

Are scleral lenses safe for me?

With careful fitting and hygiene, they are a mainstay for GVHD dryness. We train you thoroughly and follow closely.

What is ocular graft-versus-host disease?

Ocular graft-versus-host disease (GVHD) is eye involvement in GVHD, a complication of a bone marrow or stem cell transplant in which the newly transplanted donor cells attack the recipient's body. Its exact cause is unknown, but it likely comes from an immune reaction between the donor's and the recipient's cells. In the eyes it commonly causes dry eye, light sensitivity and repeated breakdown of the cornea's clear surface layer. It occurs only after transplants that use a donor's cells, since donor cells drive it.

How is ocular GVHD treated?

In stages, matched to severity and stepped up until the surface is comfortable and protected. Care starts with preservative-free artificial tears and prescription anti-inflammatory drops, then adds punctal plugs (tiny plugs that keep tears from draining away) once the surface is not inflamed. Autologous serum drops, made from your own blood, help in select cases, and scleral lenses, a type the FDA has cleared for GVHD eye disease, become the daily shield for advanced disease. Your systemic GVHD treatment shapes the plan, so findings go to your transplant team.

Medically reviewed by Dr. Bijan Cohenmehr, OD Last reviewed October 24, 2026

Ocular Graft-Versus-Host Disease

Dry eye after transplant is its own disease.

After a bone marrow or stem cell transplant, donor immune cells can target the body’s moisture systems — including the tear glands and eye surface. Ocular GVHD produces severe, persistent dryness with surface damage, and it deserves specialty-level care coordinated with your transplant team.

Book appointmentOr call 310-828-2010 Accepted insurance

After: Bone marrow / stem cell transplant
Attacks: Tear glands and eye surface
Care: Staged, with your transplant team
Advanced: Scleral lenses, serum tears

Tell your transplant team and us if you notice

Burning, grittiness or light sensitivity after transplant
Stringy mucus and fluctuating vision
Drops helping for minutes, not hours
Pain with wind, air conditioning or reading

Why sclerals matter here

Scleral lenses hold a reservoir of preservative-free saline over the cornea all day — protection and comfort for surfaces that GVHD keeps raw. They are among the most effective tools for this disease.

Scleral lenses →

Treatment

Staged care, escalated to effect.

Aggressive preservative-free lubrication and nighttime protection
Anti-inflammatory prescription therapy for the surface
Punctal plugs to retain tears once inflammation is managed
Autologous serum drops in select cases
Scleral lenses as the daily shield for advanced surface disease
Reports shared with your transplant and oncology team

Coordination

Your transplant team stays in the loop.

Findings and progress reported to your physicians
Flare-ups seen promptly
Care sequenced around your systemic treatment

Call 310-828-2010

Common questions

Ocular GVHD, answered.

Anything else, call the office at 310-828-2010.

Often in the chronic phase, months after transplant — any new eye symptoms after transplant deserve prompt evaluation.
It is controlled rather than cured: the goal is a comfortable, protected surface and preserved vision while your systemic disease is managed.
With careful fitting and hygiene, they are a mainstay for GVHD dryness. We train you thoroughly and follow closely.
Ocular graft-versus-host disease (GVHD) is eye involvement in GVHD, a complication of a bone marrow or stem cell transplant in which the newly transplanted donor cells attack the recipient's body. Its exact cause is unknown, but it likely comes from an immune reaction between the donor's and the recipient's cells. In the eyes it commonly causes dry eye, light sensitivity and repeated breakdown of the cornea's clear surface layer. It occurs only after transplants that use a donor's cells, since donor cells drive it.
In stages, matched to severity and stepped up until the surface is comfortable and protected. Care starts with preservative-free artificial tears and prescription anti-inflammatory drops, then adds punctal plugs (tiny plugs that keep tears from draining away) once the surface is not inflamed. Autologous serum drops, made from your own blood, help in select cases, and scleral lenses, a type the FDA has cleared for GVHD eye disease, become the daily shield for advanced disease. Your systemic GVHD treatment shapes the plan, so findings go to your transplant team.

Also consider

Next step

Post-transplant eyes need a plan.

Book an evaluation with a Los Angeles eye doctor and we’ll coordinate with your transplant team.

Book Today Or call 310-828-2010